Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

EMBO Journal

Volumn 17, Issue 6, 1998, Pages 1700-1709

  Kilger, Ellen ^a   Kieser, Arnd ^a   Baumann, Matthias ^a   Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

B cells; CD40 receptor; Epstein Barr virus; LMP1

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL IMMORTALIZATION; CELL PROLIFERATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANTIGENS, CD40; B-LYMPHOCYTES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TETRACYCLINE; VIRAL MATRIX PROTEINS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032536860     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.6.1700     Document Type: Article

References (58)

1. Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A. and Clifford, K.N. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature, 357, 80-82.
2. Avvedimento, V.E., Musti, A.M., Ueffing, M., Obici, S., Gallo, A., Sanchez, M., DeBrasi, D. and Gottesman, M.E. (1991) Reversible inhibition of a thyroid-specific transacting factor by ras. Genes Dev., 5, 22-28.
3. Baichwal, V.R. and Sugden, B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene, 2, 461-467.
4. Banchereau, J. and Rousset, F. (1991) Growing human B lymphocytes in the CD40 system. Nature, 353, 678-679.
5. Banchereau, J., de Paoli, P., Valle, A., Garcia, E. and Rousset, F. (1991) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science, 251, 70-72.
6. Barrett, T.B., Shu, G. and Clark, E.A. (1991) CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol., 146, 1722-1729.
7. Berberich, I., Shu, G.L. and Clark, E.A. (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol., 153, 4357-4366.
8. Berberich, I., Shu, G., Siebelt, F., Woodgett, J.R., Kyriakis, J.M. and Clark, E.A. (1996) Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J., 15, 92-101.
9. Brodeur, S.R., Cheng, G., Baltimore, D. and Thorley-Lawson, D.A. (1997) Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem., 272, 19777-19784.
10. Cheng, G., Cleary, A.M., Ye, Z.S., Hong, D.I., Lederman, S. and Baltimore, D. (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science, 267, 1494-1498.
11. Clark, E.A. and Shu, G. (1990) Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol., 145, 1400-1406.
12. Cohen, J.I., Wang, F., Mannick, J. and Kieff, E. (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA, 86, 9558-9562.
13. Deuschle, U., Meyer, W.K. and Thiesen, H.J. (1995) Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol., 15, 1907-1914.
14. Devergne, O., Hatzivassiliou, E., Izumi, K.M., Kaye, K.M., Kleijnen, M.F., Kieff, E. and Mosialos, G. (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol., 16, 7098-7108.
15. Duckett, C.S., Gedrich, R.W., Gilfillan, M.C. and Thompson, C.B. (1997) Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol., 17, 1535-1542.
16. Eliopoulos, A.G., Stack, M., Dawson, C.W., Kaye, K.M., Hodgkin, L., Sihota, S., Rowe, M. and Young, L.S. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene, 14, 2899-2916.
17. Fennewald, S., van Santen, V. and Kieff, E. (1984) Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol., 51, 411-419.
18. Galibert, L., Burdin, N., de Saint-Vis, B., Garrone, P., Van Kooten, C., Banchereau, J. and Rousset, F. (1996) CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med., 183, 77-85.
19. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D. and Hammerschmidt, W. (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J., 16, 6131-6140.
20. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
21. Hammarskjold, M.L. and Simurda, M.C. (1992) Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol., 66, 6496-6501.
22. Hammerschmidt, W. and Sugden, B. (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell, 55, 427-433.
23. Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, 340, 393-397.
24. Hennessy, K., Fennewald, S., Hummel, M., Cole, T. and Kieff, E. (1984) A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. Natl Acad. Sci. USA, 81, 7207-7211.
25. Hollenbaugh, D., Grosmaire, L.S., Kullas, C.D., Chalupny, N.J., Braesch-Andersen, S., Noelle, R.J., Stamenkovic, I., Ledbetter, J.A. and Aruffo, A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J., 11, 4313-4321.
26. Hsu, H., Xiong, J. and Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell, 81, 495-504.
27. Huen, D.S., Henderson, S.A., Croom-Carter, D. and Rowe, M. (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene, 10, 549-560.
28. Kansas, G.S. and Tedder, T.F. (1991) Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol., 147 4094-4102.
29. Kaye, K.M., Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
30. Kempkes, B., Pich, D., Zeidler, R. and Hammerschmidt, W. (1995a) Immortalization of human primary B-lymphocytes in vitro with DNA. Proc. Natl Acad. Sci. USA, 92, 5875-5879.
31. Kempkes, B., Pich, D., Zeidler, R., Sugden, B. and Hammerschmidt, W. (1995b) Immortalization of human B-lymphocytes by a plasmid containing 71 kpb of Epstein-Barr viral DNA. J. Virol., 69, 231-238.
32. 1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J., 14, 88-96.
33. Kieff, E. (1996) Epstein-Barr virus and its replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Monath, T.P., Melnick, J.L., Roizman, B. and Straus, S.E. (eds), Virology. Lippincott-Raven Publishers, Philadelphia, PA, pp. 2343-2396.
34. Kieser, A. et al. (1996) Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells. Genes Dev., 10, 1455-1466.
35. Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J., 16, 6478-6485.
36. Kuhné, M.R., Robbins, M., Hambor, J.E., Mackey, M.F., Kosaka, X., Nishimura, T., Gigley, J.P., Noelle, R.J. and Calderhead, D.M. (1997) Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med., 186, 337-342.
37. Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F. and Dixit, V.M. (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem., 267, 24157-24160.
38. Laman, J.D., Claassen, E. and Noelle, R.J. (1996) Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol., 16, 59-108.
39. Liebowitz, D., Wang, D. and Kieff, E. (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol., 58, 233-237.
40. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
41. Mitchell, T. and Sugden, B. (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol., 69, 2968-2976.
42. Moorthy, R.K. and Thorley-Lawson, D.A. (1993) All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol., 67, 1638-1646.
43. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
44. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
45. Noelle, R.J., Roy, M., Shepherd, D.M., Stamenkovic, I., Ledbetter, J.A. and Aruffo, A. (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl Acad. Sci. USA, 89, 6550-6554.
46. O'Connor, M., Peifer, M. and Bender, W. (1989) Construction of large DNA segments in Escherichia coli. Science, 244, 1307-1312.
47. Rabson, M., Gradoville, L., Heston, L. and Miller, G. (1982) Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol., 44, 834-844.
48. Rickinson, A.B. and Kieff, E. (1996) Epstein-Barr virus. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T., Roizman, B. and Straus, S.E. (eds), Virology. 3rd edn. Lippincott-Raven Publishers, Philadelphia, PA, pp. 2397-2446.
49. Rothe, M., Sarma, V., Dixit, V.M. and Goeddel, D.V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science, 269, 1424-1427.
50. Sandberg, M., Hammerschmidt, W. and Sugden, B. (1997) Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol., 71, 4649-4656.
51. Sarma, V., Lin, Z., Clark, L., Rust, B.M., Tewari, M., Noelle, R.J. and Dixit, V.M. (1995) Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem., 270, 12343-12346.
52. Tomkinson, B., Robertson, E. and Kieff, E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67, 2014-2025.
53. Tsitsikov, E.N., Wright, D.A. and Geha, R.S. (1997) CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Proc. Natl Acad. Sci. USA, 94, 1390-1395.
54. Wang, D., Liebowitz, D. and Kieff, E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
55. Yates, J.L. (1996) Epstein-Barr virus DNA replication. In DePamphilis, M.L. (ed.), DNA Replication in Eukaryotic Cells. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY, pp. 751-773.
56. Zeidler, R., Eißner, G., Meißner, P., Uebel, S., Tampé, R., Lazis, S. and Hammerschmidt, W. (1997) Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood, 90, 2390-2397.
57. Zimber-Strobl, U., Strobl, L.J., Meitinger,., Hinrichs, R., Sakai, T., Furukawa, T., Honjo, T. and Bornkamm, G.W. (1994) Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila Suppressor of Hairless. EMBO J., 13, 4973-4982.
58. Zimber-Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., Van Kooten, C., Banchereau, J., Bornkamm, G.W. and Hammerschmidt, W. (1996) Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B-cells but both it and activated CD40 can prolong their survival. EMBO J., 15, 7070-7078.